EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Basic concepts of cancer genetics and receptor tyrosine kinase inhibition for pharmacists. A narrative review

Kathleen B Orrico iD

Journal of Oncology Pharmacy Practice · 2023

DOI: 10.1177/10781552231153814 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Oncology Pharmacy Practice, 2023. Verfasst von Kathleen B Orrico. Beteiligte Einrichtung: University of California San Francisco School of Pharmacy, Palo Alto, Menlo Park, CA 94025, USA. Hauptthemen laut MEDLINE: Receptor Protein-Tyrosine Kinases, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intent of this review is to present basic genetic concepts key to understanding oncogenesis and the role receptor tyrosine kinase (RTK) inhibition plays in the targeted treatment of many cancer types. Oncogenic signaling by RTKs can result from genetic events such as point mutations, chromosomal rearrangements, structural variation, and gene amplification in the cancer genome. The cancer pharmacogenes discussed encode RTKs that exemplify the link between gene variation, the oncogenic process, and the basis of targeted approaches to treatment. Biochemical pathways often involved in oncogenesis and affected by RTK variation are reviewed. Molecular diagnostic testing for the presence of specific gene variants, alterations, and amplifications direct therapy to indicated tyrosine kinase inhibitors and monoclonal antibody drugs. As pharmacists are integral to the selection, preparation, and monitoring of chemotherapy, it is important that they understand the genetic basis for targeted therapies as well as the underlying disease process.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor Protein-Tyrosine KinasesNeoplasmsHumansPharmacistsSignal TransductionCarcinogenesisProtein Kinase Inhibitors

Stichwörter der Autor:innen

Receptor tyrosine kinasecancermolecular diagnosticspharmacogenomicstyrosine kinase inhibitors

Substanzen

Receptor Protein-Tyrosine KinasesProtein Kinase Inhibitors

Autor:innen und Institutionen

  • University of California San Francisco School of Pharmacy, Palo Alto, Menlo Park, CA 94025, USA.

ORCID-Profile: Kathleen B Orrico

Zitieren

APA

Orrico, K. B. (2023). Basic concepts of cancer genetics and receptor tyrosine kinase inhibition for pharmacists. A narrative review. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552231153814

Vancouver

Orrico KB. Basic concepts of cancer genetics and receptor tyrosine kinase inhibition for pharmacists. A narrative review. Journal of Oncology Pharmacy Practice. 2023. doi:10.1177/10781552231153814

BibTeX
@article{Orrico2023,
  author = {Orrico, Kathleen B},
  title = {Basic concepts of cancer genetics and receptor tyrosine kinase inhibition for pharmacists. A narrative review},
  journal = {Journal of Oncology Pharmacy Practice},
  year = {2023},
  doi = {10.1177/10781552231153814}
}
Kostenlos starten →